Celanese Corporation an international specialty materials and chemical organization, declared the launch of iDose TR by Glaukos Corporation utilizing Celanese’s VitalDose EVA to give constant drug release for the therapy of glaucoma. Several glaucoma and ocular hypertension patients are nonconforming with topical medication utilized because of intricate dosing regimens, adverse impacts, and eye-drop discrimination.
Celanese Corporation, an international specialty materials and chemical organization, declared it has been accepted by the U.S. Department of Energy (DOE)’s Office of Fossil Energy and Carbon Management as a Utilization Procurement Grants (UPGrants) vendor. Celanese is now the only producer offering low-carbon acetic acid under the ECO-CC product name, which positions the company to help municipalities meet the growing demand for more sustainable and circular solutions.
Author Credits: Rajrani Baghel
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?